Eric has over 25 years experience in biotechnology and life sciences market assessment, valuation, marketing, management, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies and is an experienced biotechnology strategist and marketing practitioner; he and his team have advised 100s of companies on marketing strategy development, valuation, pricing and message strategy, and have developed marketing plans based on quantitative analysis of market trends and buyer needs. In 1989 he co-founded BioPlan Associates, Inc. to provide market research, valuation services, pricing strategy, and market analysis to biotechnology and healthcare organizations. His company works with both large and small clients at commercial biotechs, non-profit organizations, and governments in assessing and evaluating markets, and marketing strategies and tactics. As Strategy Advisor for the International Mergers and Acquisitions Partnership / Falls River Group of life sciences investors, he provides market insights and valuation services to senior managers at life sciences organizations to maximize shareholder value. He teaches graduate biotechnology marketing at Johns Hopkins University and biomedical valuation to the NIH Graduate School, and has developed numerous courses, and seminar programs including ROI in the Life Sciences. He has published, edited and authored numerous books, texts, and major studies including: Advances in Biopharmaceutical Technology in China, Quick Guide to Clinical Trials, Quick Guide to BioFuels, Advances in Large-scale BioManufacturing, Biopharmaceuticals in the US Market, cell culture reports, media, sera, tissue engineering, stem cells, diagnostic products, blood products, genetics, DNA/PCR purification, blood components, and many others.